|
[1]Drug-induced Liver Disease Study Group,Chinese Society of Hepatology,Chinese Medical Association.Guidelines for the management of drug-induced liver injury[J].J Clin Hepatol,2015,31(11):1752-1769.(in Chinese)中华医学会肝病学分会药物性肝病学组.药物性肝损伤诊治指南[J].临床肝胆病杂志,2015,31(11):1752-1769.
|
|
[2]THULIN P,NORDAHL G,GRY M,et al.Keratin-18 and microRNA-122 complement alanine aminotransferase as novel safety biomarkers for drug-induced liver injury in two human cohorts[J].Liver Int,2014,34(3):367-378.
|
|
[3]LAWRIE CH,GAL S,DUNLOP HM,et al.Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma[J].Brit J Haematol,2008,141(5):672-675.
|
|
[4]LI LM,WANG D,ZEN K,et al.MicroRNAs in drug-induced liver injury[J].J Clin Transl Hepatol,2014,2(3):162-169.
|
|
[5]STARKEY LEWIS PJ,DEAR J,PLATT V,et al.Circulating microRNAs as potential markers of human drug-induced liver injury[J].Hepatology,2011,54(5):1767-1776.
|
|
[6]YANG X,GREENHAW J,SHI Q,et al.Identification of urinary microRNA profiles in rats that may diagnose hepatotoxicity[J].Toxicol Sci,2012,125(2):335-344.
|
|
[7]VLIEGENTHART AD,ANTOINE DJ,DEAR JW,et al.Target biomarker profile for the clinical management of paracetamol overdose[J].Br J Clin Pharmacol,2015,80(3):351-362.
|
|
[8]ANTOINE DJ,JENKINS RE,DEAR JW,et al.Molecular forms of HMGB1 and keratin-18 as mechanistic biomarkers for mode of cell death and prognosis during clinical acetaminophen hepatotoxicity[J].J Hepatol,2012,56(5):1070-1079.
|
|
[9]CRAIG DG,LEE P,PRYDE EA,et al.Circulating apoptotic and necrotic cell death markers inpatients with acute liver injury[J].Liver Int,2011,31(8):1127-1136.
|
|
[10]ANTOINE DJ,WILLIAMS DP,KIPAR A,et al.High Mobility Group Box-1 protein and Keratin-18,circulating serum proteins informative of acetaminophen-induced necrosis and apoptosis in vivo[J].Toxicol Sci,2009,112(2):521-531.
|
|
[11]LOTZE MT,TRACEY KJ.High-mobility group box 1 protein(HMGB1):nuclear weapon in the immune arsenal[J].Nat Rev Immunol,2005,5(4):331-342.
|
|
[12]BONALDI T,TALAMO F,SCAFFIDI P,et al.Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion[J].Embo J,2003,22(20):5551-5560.
|
|
[13]ANTOINE DJ,DEAR JW,LEWIS PS,et al.Mechanistic biomarkers provide early and sensitive detection of acetaminophen‐induced acute liver injury at first presentation to hospital[J].Hepatology,2013,58(2):777-787
|
|
[14]RUHL CE,EVERHART JE.Relation of elevated serum alanine aminotransferase activity with iron and antioxidant levels in the United States[J].Gastroenterology,2003,124(7):1821-1829.
|
|
[15]YANG RZ,PARK S,REAGAN WJ,et al.Alanine aminotransferase isoenzymes:molecular cloning and quantitative analysis of tissue expression in rats and serum elevation in liver toxicity[J].Hepatology,2009,49(2):598-607.
|
|
[16]LEE WK,SHIN S,CHO SS,et al.Purification and characterization of glutamate dehydrogenase as anotherisoprotein binding to the membrane of rough endoplasmic reticulum[J].J Cell Biochem,1999,76(2):244-253.
|
|
[17]MCGILL MR,STAGGS VS,SHARPE MR,et al.Serum mitochondrial biomarkers and damage-associated molecular patterns are higher in acetaminophen overdose patients with poor outcome[J].Hepatology,2014,60(4):1336-1345.
|
|
[18]MCGILL MR,SHARPE MR,WILLIAMS CD,et al.The mechanism underlying acetaminopheninduced hepatotoxicity in humans and mice involves mitochondrial damage and nuclear DNA fragmentation[J].Clin Invest,2012,122(4):1574-1583.
|
|
[19]SHI Q,YANG X,MATTES WB.Circulating mitochondrial biomarkers for drug-induced liver injury[J].Biomark Med,2015,9(11):1215-1223.
|
|
[20]TEGERIS AS,SMALLEY HE Jr,EARL FL,et al.Ornithine carbamyl transferase as a liver function test comparative studies in the dog,swine,and man[J].Toxicol Appl Pharmacol,1969,14(1):54-66.
|
|
[21]BONDY GS,ARMSTRONG CL,CURRAN IH,et al.Retrospective evaluation of serum ornithine carbamyltransferase activity as an index of hepatotoxicity in toxicological studies with rats[J].Toxicol Lett,2000,114(1-3):163-171.
|
|
[22]HU Z,LAUSTED C,YOO H,et al.Quantitative liver-specific protein fingerprint in blood:a signature for hepatotoxicity[J].Theranostics,2014,4(2):215-228.
|
|
[23]WEERASINGHE SV,JANG YJ,FONTANA RJ,et al.Carbamoyl phosphate synthetase-1 is a rapid turnover biomarker in mouse and human acute liver injury[J].Am J Physiol Gastrointest Liver Physiol,2014,307(3):g355-g364.
|
|
[24]MILLER TJ,KNAPTON A,ADEYEMO O,et al.Cytochrome c:a non-invasive biomarker of drug-induced liver injury[J].J Appl Toxicol,2008,28(7):815-828.
|
|
[25]KOBAYASHI Y,MORI M,NAURTO T,et al.Dynamic movement of cytochrome c from mitochondria into cytosol and peripheral circulation in massive hepatic cell injury[J].Pediat Int,2004,46(6):685-692.
|
|
[26]AMACHER DE,ADLER R,HERATH A,et al.Use of proteomic methods to identify serum biomarkers associated with rat liver toxicity or hypertrophy[J].Clin Chem,2005,51(10):1796-1803.
|
|
[27]SCHOMAKER S,WARNER R,BOCK J,et al.Assessment of emerging biomarkers of liver injury in human subjects[J].Toxicol Sci,2013,132(2):276-283.
|
|
[28]OZER J,RATNER M,SHAW M,et al.The current state of serum biomarkers of hepatotoxicity[J].Toxicology,2008,245(3):194-205.
|
|
[29]GAO H,LI N,WANG JY,et al.Definitive diagnosis of hepatic sinusoidal obstruction syndrome induced by pyrrolizidine alkaloids[J].J Dig Dis,2012,13(1):33-39.
|
|
[30]LIN G,WANG JY,LI N,et al.Hepatic sinusoidal obstruction syndrome associated with consumption of Gynura segetum[J].J Hepatol,2011,54(4):666-673.
|
|
[31]PENG SS,CUI YY,KONG WL,et al.Hepaticveno-occlusive disease induced by Gynurasegetum:a report of two cases[J].J Clin Hepatol,2015,31(7):1132-1134.(in Chinese)彭姗姗,崔园园,孔文丽,等.土三七致肝小静脉闭塞症2例报告[J].临床肝胆病杂志,2015,31(7):1132-1134.
|
|
[32]ODA S,MATSUO K,NAKAJIMA A,et al.A novel cell-based assay for the evaluation of immune-and inflammatory-related gene expression as biomarkers for the risk assessment of drug-induced liver injury[J].Toxicol Lett,2016,241:60-70.
|
|
[33]SAITO Y,KPDAMA S,SUGIYAMA E,et al.Predictive genomic markers for severe adverse drug reactions[J].Yakugaku Zasshi,2015,135(4):589-595.
|
DownLoad: